Onecrea Medical recently announced that it successfully completed first-in-human implants for its transcatheter aortic valve replacement (TAVR) system.

The company designed its next-generation TAVR system to treat aortic stenosis.

With a unique concave and convex structure, the TAVR system anchors the valve effectively in the aortic annulus. This helps to avoid common complications with TAVR, including implant dislodging or perivalvular leak (PVL) due to improper fit, according to the company.

Get the full story at our sister site, MassDevice.